High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888.
<h4>Background</h4>Many proteins that are dysregulated or mutated in cancer cells rely on the molecular chaperone HSP90 for their proper folding and activity, which has led to considerable interest in HSP90 as a cancer drug target. The diverse array of HSP90 client proteins encompasses o...
Main Authors: | Susan K Lyman, Suzanne C Crawley, Ruoyu Gong, Joanne I Adamkewicz, Garth McGrath, Jason Y Chew, Jennifer Choi, Charles R Holst, Leanne H Goon, Scott A Detmer, Jana Vaclavikova, Mary E Gerritsen, Robert A Blake |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-03-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21408192/?tool=EBI |
Similar Items
-
Correction: High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888
by: Susan K. Lyman, et al.
Published: (2011-01-01) -
Correction: High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888.
by: Susan K. Lyman, et al.
Published: (2011-01-01) -
330 Investigating the clinical safety, efficacy, and immune modulation of combined XL888 and pembrolizumab in metastatic gastrointestinal malignancies
by: Mohammad Zaidi, et al.
Published: (2020-11-01) -
The universe of Hsp90
by: Stankiewicz Marta, et al.
Published: (2012-02-01) -
High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors
by: Jason Davenport, et al.
Published: (2014-02-01)